BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 15996197)

  • 1. Lymphocyte subset differences in patients with chronic fatigue syndrome, multiple sclerosis and major depression.
    Robertson MJ; Schacterle RS; Mackin GA; Wilson SN; Bloomingdale KL; Ritz J; Komaroff AL
    Clin Exp Immunol; 2005 Aug; 141(2):326-32. PubMed ID: 15996197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pilot Study of Natural Killer Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis.
    Huth TK; Brenu EW; Ramos S; Nguyen T; Broadley S; Staines D; Marshall-Gradisnik S
    Scand J Immunol; 2016 Jan; 83(1):44-51. PubMed ID: 26381393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating lymphocyte subsets in major depression and dysthymia with typical or atypical features.
    Ravindran AV; Griffiths J; Merali Z; Anisman H
    Psychosom Med; 1998; 60(3):283-9. PubMed ID: 9625215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological abnormalities in patients with chronic fatigue syndrome.
    Tirelli U; Marotta G; Improta S; Pinto A
    Scand J Immunol; 1994 Dec; 40(6):601-8. PubMed ID: 7997849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reference ranges of lymphocyte subsets in healthy adults and adolescents with special mention of T cell maturation subsets in adults of South Florida.
    Valiathan R; Deeb K; Diamante M; Ashman M; Sachdeva N; Asthana D
    Immunobiology; 2014 Jul; 219(7):487-96. PubMed ID: 24661720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory T, natural killer T and γδ T cells in multiple sclerosis and chronic fatigue syndrome/myalgic encephalomyelitis: a comparison.
    Ramos S; Brenu E; Broadley S; Kwiatek R; Ng J; Nguyen T; Freeman S; Staines D; Marshall-Gradisnik S
    Asian Pac J Allergy Immunol; 2016 Dec; 34(4):300-305. PubMed ID: 27001659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum BAFF and APRIL Levels, T-Lymphocyte Subsets, and Immunoglobulins after B-Cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Myalgic Encephalopathy/Chronic Fatigue Syndrome.
    Lunde S; Kristoffersen EK; Sapkota D; Risa K; Dahl O; Bruland O; Mella O; Fluge Ø
    PLoS One; 2016; 11(8):e0161226. PubMed ID: 27536947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic parameters in chronic fatigue syndrome, major depression, and multiple sclerosis.
    Natelson BH; LaManca JJ; Denny TN; Vladutiu A; Oleske J; Hill N; Bergen MT; Korn L; Hay J
    Am J Med; 1998 Sep; 105(3A):43S-49S. PubMed ID: 9790481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative abnormalities of peripheral blood distinct T, B, and natural killer cell subsets and clinical findings in obstetric antiphospholipid syndrome.
    Carbone J; Gallego A; Lanio N; Navarro J; Orera M; Aguaron A; Fernandez-Cruz E; Sarmiento E
    J Rheumatol; 2009 Jun; 36(6):1217-25. PubMed ID: 19332638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal analysis of immune cell phenotypes in early stage multiple sclerosis: distinctive patterns characterize MRI-active patients.
    Rinaldi L; Gallo P; Calabrese M; Ranzato F; Luise D; Colavito D; Motta M; Guglielmo A; Del Giudice E; Romualdi C; Ragazzi E; D'Arrigo A; Dalle Carbonare M; Leontino B; Leon A
    Brain; 2006 Aug; 129(Pt 8):1993-2007. PubMed ID: 16870883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening NK-, B- and T-cell phenotype and function in patients suffering from Chronic Fatigue Syndrome.
    Curriu M; Carrillo J; Massanella M; Rigau J; Alegre J; Puig J; Garcia-Quintana AM; Castro-Marrero J; Negredo E; Clotet B; Cabrera C; Blanco J
    J Transl Med; 2013 Mar; 11():68. PubMed ID: 23514202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased expression of CD69 in chronic fatigue syndrome in relation to inflammatory markers: evidence for a severe disorder in the early activation of T lymphocytes and natural killer cells.
    Mihaylova I; DeRuyter M; Rummens JL; Bosmans E; Maes M
    Neuro Endocrinol Lett; 2007 Aug; 28(4):477-83. PubMed ID: 17693977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical improvement in chronic fatigue syndrome is not associated with lymphocyte subsets of function or activation.
    Peakman M; Deale A; Field R; Mahalingam M; Wessely S
    Clin Immunol Immunopathol; 1997 Jan; 82(1):83-91. PubMed ID: 9000046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of adaptive and innate immune cells in chronic fatigue syndrome/myalgic encephalomyelitis.
    Brenu EW; Huth TK; Hardcastle SL; Fuller K; Kaur M; Johnston S; Ramos SB; Staines DR; Marshall-Gradisnik SM
    Int Immunol; 2014 Apr; 26(4):233-42. PubMed ID: 24343819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysfunction of natural killer activity in a family with chronic fatigue syndrome.
    Levine PH; Whiteside TL; Friberg D; Bryant J; Colclough G; Herberman RB
    Clin Immunol Immunopathol; 1998 Jul; 88(1):96-104. PubMed ID: 9683556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression.
    Maes M; Twisk FN; Ringel K
    Psychother Psychosom; 2012; 81(5):286-95. PubMed ID: 22832503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in immune parameters seen in Gulf War veterans but not in civilians with chronic fatigue syndrome.
    Zhang Q; Zhou XD; Denny T; Ottenweller JE; Lange G; LaManca JJ; Lavietes MH; Pollet C; Gause WC; Natelson BH
    Clin Diagn Lab Immunol; 1999 Jan; 6(1):6-13. PubMed ID: 9874656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune and hemorheological changes in chronic fatigue syndrome.
    Brenu EW; Staines DR; Baskurt OK; Ashton KJ; Ramos SB; Christy RM; Marshall-Gradisnik SM
    J Transl Med; 2010 Jan; 8():1. PubMed ID: 20064266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic abnormalities associated with chronic fatigue syndrome.
    Barker E; Fujimura SF; Fadem MB; Landay AL; Levy JA
    Clin Infect Dis; 1994 Jan; 18 Suppl 1():S136-41. PubMed ID: 8148441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered functional B cell subset populations in patients with chronic fatigue syndrome compared to healthy controls.
    Bradley AS; Ford B; Bansal AS
    Clin Exp Immunol; 2013 Apr; 172(1):73-80. PubMed ID: 23480187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.